/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/beacon-protocols/,/clinical/cckm-tools/content/beacon-protocols/supportive-care/,

/clinical/cckm-tools/content/beacon-protocols/supportive-care/name-122943-en.cckm

201711331

page

100

UWHC,UWMF,

Tools,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Beacon Protocols,Supportive Care

CSC SC Goserelin (Zoladex) 10.8 mg Every 3 Months X 4 Ver 11-20-17 (HL 1878)

CSC SC Goserelin (Zoladex) 10.8 mg Every 3 Months X 4 Ver 11-20-17 (HL 1878) - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Beacon Protocols, Supportive Care


CSC SC GOSERELIN (ZOLADEX) 10.8MG EVERY 3 MONTHS X 4 VER: 11-20-17 –  Properties
Cycle 1 –  11/22/2017 through 2/13/2018 (84 days), Planned
Day 1, Cycle 1 –  Planned for 11/22/2017
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 10.8 mg
10.8 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 2 –  2/14/2018 through 5/8/2018 (84 days), Planned
Day 1, Cycle 2 –  Planned for 2/14/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 10.8 mg
10.8 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 3 –  5/9/2018 through 7/31/2018 (84 days), Planned
Day 1, Cycle 3 –  Planned for 5/9/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 10.8 mg
10.8 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 4 –  8/1/2018 through 10/23/2018 (84 days), Planned
Day 1, Cycle 4 –  Planned for 8/1/2018
Pre-Medications
lidocaine 1 % vial
1-5 mL, Subcutaneous, ONCE, 1 dose Starting when released
Supportive Care Medications
goserelin (ZOLADEX) drug implant NF 10.8 mg
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
ZZtestonc,Andrew [2428787]
11/22/2017 1:14:00 PM Page 1 of 2
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised: 11/2017CCKM@uwhealth.org

10.8 mg, Subcutaneous, ONCE, 1 dose Starting when released
ZZtestonc,Andrew [2428787]
11/22/2017 1:14:00 PM Page 2 of 2
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org